Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. (1st January 2019)
- Record Type:
- Journal Article
- Title:
- Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. (1st January 2019)
- Main Title:
- Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
- Authors:
- Ni, Jia-Yan
Fang, Zhu-Ting
An, Chao
Sun, Hong-Liang
Huang, Zhi-Mei
Zhang, Tian-Qi
Jiang, Xiong-Ying
Chen, Yao-Ting
Xu, Lin-Feng
Huang, Jin-Hua - Abstract:
- Abstract: Purpose: To compare the predictive value of albumin-bilirubin (ALBI) grade, platelet-ALBI (PALBI) grade and Child-Turcotte-Pugh (CTP) class in patients with large hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) combined with microwave ablation (TACE-MWA). Methods: A total of 349 consecutive HCC patients (89.1% male; mean [± SD] age 53.4 ± 12.27 years) from three medical centers, who underwent TACE-MWA for up to 3 HCCs with maximum diameters of 5.1–8.0 cm between January 2000 and June 2018, were investigated. Overall survival (OS) and progression-free survival (PFS) were analyzed. The prognostic performances of ALBI grade, PALBI grade and CTP class were compared. Results: TACE procedures were performed using lobaplatin (20–50 mg), epirubicin (30–60 mg), lipiodol (5–25 mL) and gelatin sponge particles (350–560 μm). The end point of the TACE procedure was stasis of blood flow in the feeder artery. The median follow-up duration was 28.0 months, the median OS was 28.0 months (95% confidence interval [CI] 23.55–32.45 months), and the median PFS was 4.8 months (95% CI 4.26–5.34 months). Patients with a ablation margin size of 11–15 mm experienced better PFS than those with a margin size of 6–10 or 0–5 mm (median, 6.5 versus [vs] 4.0 vs 2.3 months; p < .001). PALBI grade demonstrated significantly greater area under the curve values than ALBI grade or CTP class in predicting 1-, 3- and 5-year OS. Conclusions: PALBI grade provided betterAbstract: Purpose: To compare the predictive value of albumin-bilirubin (ALBI) grade, platelet-ALBI (PALBI) grade and Child-Turcotte-Pugh (CTP) class in patients with large hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) combined with microwave ablation (TACE-MWA). Methods: A total of 349 consecutive HCC patients (89.1% male; mean [± SD] age 53.4 ± 12.27 years) from three medical centers, who underwent TACE-MWA for up to 3 HCCs with maximum diameters of 5.1–8.0 cm between January 2000 and June 2018, were investigated. Overall survival (OS) and progression-free survival (PFS) were analyzed. The prognostic performances of ALBI grade, PALBI grade and CTP class were compared. Results: TACE procedures were performed using lobaplatin (20–50 mg), epirubicin (30–60 mg), lipiodol (5–25 mL) and gelatin sponge particles (350–560 μm). The end point of the TACE procedure was stasis of blood flow in the feeder artery. The median follow-up duration was 28.0 months, the median OS was 28.0 months (95% confidence interval [CI] 23.55–32.45 months), and the median PFS was 4.8 months (95% CI 4.26–5.34 months). Patients with a ablation margin size of 11–15 mm experienced better PFS than those with a margin size of 6–10 or 0–5 mm (median, 6.5 versus [vs] 4.0 vs 2.3 months; p < .001). PALBI grade demonstrated significantly greater area under the curve values than ALBI grade or CTP class in predicting 1-, 3- and 5-year OS. Conclusions: PALBI grade provided better predictive value than ALBI grade or CTP class in patients with large HCCs after TACE-MWA. … (more)
- Is Part Of:
- International journal of hyperthermia. Volume 36:Number 1(2019)
- Journal:
- International journal of hyperthermia
- Issue:
- Volume 36:Number 1(2019)
- Issue Display:
- Volume 36, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 36
- Issue:
- 1
- Issue Sort Value:
- 2019-0036-0001-0000
- Page Start:
- 840
- Page End:
- 852
- Publication Date:
- 2019-01-01
- Subjects:
- Hepatocellular carcinoma -- transarterial chemoembolization -- microwave ablation -- hepatic function -- prognosis
Thermotherapy -- Periodicals
615.832 - Journal URLs:
- http://informahealthcare.com/loi/hth ↗
http://www.tandf.co.uk/journals/titles/02656736.asp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/02656736.2019.1646927 ↗
- Languages:
- English
- ISSNs:
- 0265-6736
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.297000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12726.xml